[
  {
    "ts": null,
    "headline": "Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day",
    "summary": "Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=112500ae3ffce6203fd3be83324fb823a86114479adbc6ff184b1289307b6008",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755018480,
      "headline": "Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day",
      "id": 136398766,
      "image": "",
      "related": "ZBH",
      "source": "MarketWatch",
      "summary": "Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=112500ae3ffce6203fd3be83324fb823a86114479adbc6ff184b1289307b6008"
    }
  },
  {
    "ts": null,
    "headline": "ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story",
    "summary": "Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.",
    "url": "https://finnhub.io/api/news?id=442ef3ca875d1f1990dd60d091392176d881425a55d66b2414abd7d887b9ce74",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1755001080,
      "headline": "ISRG's Post-Earnings Slide: Margin Worries Overshadow Growth Story",
      "id": 136320675,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's Q2 revenues and procedure gains look good, but tariffs, cost inflation, and margin pressure spur a post-earnings selloff.",
      "url": "https://finnhub.io/api/news?id=442ef3ca875d1f1990dd60d091392176d881425a55d66b2414abd7d887b9ce74"
    }
  },
  {
    "ts": null,
    "headline": "ZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades",
    "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=7f5795a17a9b56612780dac05e825630bef18cbbd3bd386d7728eb4ed1ac79c9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1754983678,
      "headline": "ZBH Q2 Deep Dive: New Product Launches and M&A Drive Guidance Upgrades",
      "id": 136316561,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ZBH",
      "source": "Yahoo",
      "summary": "Medical device company Zimmer Biomet (NYSE:ZBH) announced better-than-expected revenue in Q2 CY2025, with sales up 7% year on year to $2.08 billion. Its non-GAAP profit of $2.07 per share was 4.8% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=7f5795a17a9b56612780dac05e825630bef18cbbd3bd386d7728eb4ed1ac79c9"
    }
  }
]